American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1051-1060, December 2008

Mortality Risks for All Causes and Cardiovascular Diseases and Reduced GFR in a Middle-aged Working Population in Taiwan

  • Ting-Yuan David Cheng, MS

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Sung-Feng Wen, MD

      Affiliations

    • Department of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI
  • ,
  • Brad C. Astor, PhD, MPH

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
    • Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD
  • ,
  • Xuguang (Grant) Tao, MD, PhD

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Jonathan M. Samet, MD, MS

      Affiliations

    • Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
  • ,
  • Chi Pang Wen, MD, DrPH

      Affiliations

    • Center for Health Policy Research and Development, National Health Research Institutes, Taiwan
    • Corresponding Author InformationAddress correspondence to Chi Pang Wen, MD, DrPH, 35 Keyan Rd, Zhunan Town, Miaoli County 350, Taiwan

Received 15 December 2007; accepted 12 May 2008. published online 15 August 2008.

Background

Effects of decreased estimated glomerular filtration rate (eGFR) on cardiovascular disease (CVD) mortality are uncertain in Chinese general populations.

Study Design

Prospective cohort study.

Setting & Participants

17,026 adults 50 years and older in Taiwan. A subset of 7,968 had repeated measurements.

Predictor

Decreased eGFR and its progression. eGFR was calculated from serum creatinine level by using the Modification of Diet in Renal Disease Study equation.

Outcomes

Mortality from all causes and CVD, including coronary heart disease (CHD) and stroke, from the National Death Registry.

Measurements

Hazard ratios (HRs) and Kaplan-Meier survival curves were calculated for participants with a moderate to severe decrease in eGFR (<60 mL/min/1.73 m2) compared with those with normal eGFR (≥90 mL/min/1.73 m2). HR of a rapid decrease (≥20%) in eGFR was also calculated.

Results

Mean age of all participants was 57.2 ± 5.2 (SD) years. We observed 1,682 deaths in 15 years of follow-up. Participants with a moderate to severe decrease in eGFR had increased HRs for mortality from all causes (1.44; 95% confidence interval [CI], 1.22 to 1.70), CVD (1.90; 95% CI, 1.36 to 2.65), CHD (2.07; 95% CI, 1.26 to 3.41), and stroke (2.16; 95% CI, 1.29 to 3.62) after adjusting for confounders. Decreased eGFR was associated with ischemic stroke, but not hemorrhagic stroke. No significant interaction between decreased eGFR and anemia, diabetes, or smoking was found. There were 660 participants with a 20% or greater decrease in eGFR from baseline during 18 months of follow-up. They had increased HRs for all causes (1.45; 95% CI, 1.13 to 1.86), CVD (2.48; 95% CI, 1.58 to 3.89), CHD (2.14; 95% CI, 1.07 to 4.29), and stroke (2.79; 95% CI, 1.45 to 5.36) compared with those with less than a 20% decrease in eGFR during the same period.

Limitations

Data for proteinuria were not available. Creatinine assay was not calibrated.

Conclusions

A moderate to severe or fast decrease in eGFR was associated with all-cause and CVD mortality in this ethnic Chinese cohort.

Index Words: Reduced estimated glomerular filtration rate (eGFR), cardiovascular disease, cohort study

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Originally published online as doi:10.1053/j.ajkd.2008.05.030 on August 13, 2008.

PII: S0272-6386(08)01006-8

doi:10.1053/j.ajkd.2008.05.030

American Journal of Kidney Diseases
Volume 52, Issue 6 , Pages 1051-1060, December 2008